Mélanie Flaender
Head of Project Management Cytoo
Seminars
Wednesday 28th October 2026
Muscle Preservation in Obesity Therapy: How Drug Developers Can Take Advantage of MyoScreen™ to Distinguish Direct From Systemically-Mediated Drug Effects on Human Muscle
12:45 pm
- Investigation of GLP-1 agonist effects in human myotubes
- Benchmarking an ALK5 inhibitor against bimagrumab across muscle-related assays
- Towards a broader investigation of muscle functions in situations of wasting
